The Effect of Myoma uteri on Infertility:

Paweena Phaliwong

doi:10.33192/Smj.2020.60

Authors

Paweena Phaliwong Reproductive Medicine Unit, Department of Obstetrics and Gynecology, Bhumibol Adulyadej Hospital, Royal Thai Air Force, Thailand http://orcid.org/0000-0002-2407-1714

DOI:

https://doi.org/10.33192/Smj.2020.60

Keywords:

Myoma uteri, Infertility

Abstract

Myoma uteri are the most prevalent firm of benign gynecological tumors found in women. Their effects on reproductive function and fertility are unknown. Treatment is dependent on myoma's location and size. While there is medical consensus on the treatment of submucosal myoma, there exists controversy in treatment and management of intramural myoma in infertile patients. Surgical treatments include hysteroscopic, laparoscopic and open myomectomies (laparotomy). Results from endoscopic and open myomectomies are comparable. Endoscopic treatment is generally favored due to lower morbidity, same day treatment, shorter hospitalizations and lower costs. Alternative methods, including medical and radiological intervention, are discussed.

References

Zepiridis LI, Grimbizis GF, Tarlatzis BC. Infertility and uterine fibroids. Best Pract Res Clin Obstet Gynaecol 2016;34:66-73.

Lisiecki M, Paszkowski M, Woźniak S Fertility impairment associated with uterine fibroids - a review of literature. Prz Menopauzalny 2017;16:137-40.

Purohit P, Vigneswaran K. Fibroids and Infertility. Curr Obstet Gynecol Rep 2016;5:81-8.

Ben-Nagi J, Miell J, Mavrelos D, Naftalin J, Lee C, Jurkovic D. Endometrial implantation factors in women with submucous uterine fibroids. Reprod Biomed Online 2010;21:610-5.

Kitaya K, Yasuo T. Leukocyte density and composition in human cycling endometrium with uterine fibroids. Hum Immunol. 2010;71:161–63.

Cakmak H, Taylor HS. Implantation failure: molecular mechanisms and clinical treatment. Hum Reprod Update 2011;17:242-53.

Matsuzaki S, Canis M, Darcha C, Pouly JL, Mage G. HOXA-10 expression in the mid-secretory endometrium of infertile patients with either endometriosis, uterine fibromas or unexplained infertility. Hum Reprod 2009;24:3180-7.

Rackow BW, Taylor HS. Submucosal uterine leiomyomas have a global effect on molecular determinants of endometrial receptivity. Fertil Steril. 2010;93:2027-34.

Munro MG, Critchley HOD, Fraser IS; FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet 2018;143 393-408.

Pritts EA, Parker WH, Olive DL. Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril 2009;91:1215-23.

Casini ML, Rossi F, Agostini R, Unfer V. Effects of position of fibroids on fertility. Gynecol Endocrinol 2006;22:106-9.

Sunkara SK, Khairy M, El-Toukhy T, Khalaf Y, Coomarasamy A. The effect of intramural fibroids without uterine cavity involvement on the outcome of IVF treatment: a systematic review and meta-analysis. Hum Reprod 2010;25:418-29.

Buletti C, De Ziegler D, Polli V, Flamigni C. The role of leiomyomas in infertility. J Am Assoc Gynecol Laparosc 1999;6:441-5.

Metwally M, Cheong YC, Horne AW. Surgical treatment of fibroids for subfertility. Cochrane Database Syst Rev 2012;11:CD003857.

Carranza-Mamane B, Havelock J, Hemmings R. The management of uterine fibroids in women with otherwise unexplained infertility. J Obstet Gynaecol Can. 2015;37:277-285.

William H, Jonathan S, Deborah L. Uterine Fibroids. Berek and Novak's Gynecology.16th ed. Philadelphia: Lippincott Williams and Wilkins; 2019. p.223-50.

Siristatidis C, Vaidakis D, Rigos I, Chrelias G, Papantoniou N. Leiomyomas and infertility. Minerva Ginecol 2016;68:283-96.

Giuliani E, As-Sanie S, Marsh EE. Epidemiology and management of uterine fibroids. Int J Gynaecol Obstet 2020;149:3-9.

Donnez J, Dolmans MM. Uterine fibroid management: from the present to the future. Hum Reprod Update 2016;22:665-86.

Whynott RM, Vaught KCC, Segars JH. The Effect of Uterine Fibroids on Infertility: A Systematic Review. Semin Reprod Med 2017;35:523-32.

Donnez J, Donnez O, Dolmans MM. With the advent of selective progesterone receptor modulators, what is the place of myoma surgery in current practice? Fertil Steril 2014;102:640-8.

Donnez J, Hudecek R, Donnez O, Matule D, Arhendt HJ, Zatik J, et al. Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids. Fertil Steril 2015;103:519-27.

Lo Monte G, Piva I, Graziano A, Engl B, Marci R. Ulipristal acetate prior to in vitro fertilization in a female patient affected by uterine fibroids: a case report. Eur Rev Med Pharmacol Sci 2016;20:202-7.

Parsanezhad ME, Azmoon M, Alborzi S, Rajaeefard A, Zarei A, Kazerooni T, et al. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status. Fertil Steril 2010;93:192-8.

Kashani BN, Centini G, Morelli SS, Weiss G, Petraglia F. Role of medical management for uterine leiomyomas. Best Pract Res Clin Obstet Gynaecol 2016;34:85-103.

Frishman GN, Jurema MW. Myomas and myomectomy. J Minim Invasive Gynecol 2005;12:443-56.

Van Heertum K, Barmat L. Uterine fibroids associated with infertility. Womens Health (Lond) 2014;10:645-53.

Torre A, Fauconnier A, Kahn V, Limot O, Bussierres L, Pelage JP. Fertility after uterine artery embolization for symptomatic multiple fibroids with no other infertility factors. Eur Radiol 2017;27:2850-59.

Rabinovici J, David M, Fukunishi H, Morita Y, Gostout BS, Stewart EA; MRgFUS Study Group. Pregnancy outcome after magnetic resonance-guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids. Fertil Steril 2010;93:199-209.